+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Tazobactam"

From
From
Antibacterial Drugs Market Report 2024-2034 - Product Thumbnail Image

Antibacterial Drugs Market Report 2024-2034

  • Report
  • January 2024
  • 269 Pages
  • Global
From
From
From
  • 6 Results (Page 1 of 1)
Loading Indicator

Tazobactam is an antibiotic used in combination with other antibiotics to treat a variety of bacterial infections. It is a beta-lactamase inhibitor, which means it prevents bacteria from breaking down the antibiotics, allowing them to work more effectively. Tazobactam is often used in combination with piperacillin, a broad-spectrum antibiotic, to treat serious infections such as pneumonia, sepsis, and urinary tract infections. It is also used to treat infections caused by multi-drug resistant bacteria. Tazobactam is available in both injectable and oral forms, and is approved for use in adults and children. It is generally well-tolerated, with few side effects. However, it can cause allergic reactions in some people. The tazobactam market is a growing segment of the antibiotics market, as it is increasingly used to treat multi-drug resistant infections. It is also used in combination with other antibiotics to treat a variety of bacterial infections. Some companies in the tazobactam market include Merck, Pfizer, GlaxoSmithKline, and AstraZeneca. Show Less Read more